Cite
APA Citation
Pai, V., Paneerselvam, A., Mukhopadhyay, S., Bhansali, A., Kamath, D., Shankar, V., Gambhire, D., Jani, R. H., Joshi, S., & Patel, P. (n.d.). a Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V). Journal of diabetes science and technology, 8, 132–141. http://access.bl.uk/ark:/81055/vdc_100059249811.0x000057